全文获取类型
收费全文 | 3405篇 |
免费 | 114篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 88篇 |
妇产科学 | 40篇 |
基础医学 | 268篇 |
口腔科学 | 67篇 |
临床医学 | 234篇 |
内科学 | 781篇 |
皮肤病学 | 46篇 |
神经病学 | 128篇 |
特种医学 | 50篇 |
外科学 | 474篇 |
综合类 | 474篇 |
预防医学 | 368篇 |
眼科学 | 42篇 |
药学 | 283篇 |
3篇 | |
中国医学 | 71篇 |
肿瘤学 | 98篇 |
出版年
2024年 | 2篇 |
2023年 | 34篇 |
2022年 | 65篇 |
2021年 | 75篇 |
2020年 | 58篇 |
2019年 | 339篇 |
2018年 | 283篇 |
2017年 | 131篇 |
2016年 | 42篇 |
2015年 | 48篇 |
2014年 | 142篇 |
2013年 | 111篇 |
2012年 | 113篇 |
2011年 | 124篇 |
2010年 | 108篇 |
2009年 | 98篇 |
2008年 | 88篇 |
2007年 | 84篇 |
2006年 | 74篇 |
2005年 | 48篇 |
2004年 | 33篇 |
2003年 | 26篇 |
2002年 | 26篇 |
2001年 | 26篇 |
2000年 | 21篇 |
1999年 | 17篇 |
1998年 | 4篇 |
1997年 | 14篇 |
1996年 | 7篇 |
1995年 | 3篇 |
1994年 | 6篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1988年 | 5篇 |
1986年 | 2篇 |
1985年 | 109篇 |
1984年 | 174篇 |
1983年 | 127篇 |
1982年 | 146篇 |
1981年 | 124篇 |
1980年 | 112篇 |
1979年 | 103篇 |
1978年 | 77篇 |
1977年 | 54篇 |
1976年 | 64篇 |
1975年 | 63篇 |
1974年 | 49篇 |
1973年 | 40篇 |
1972年 | 3篇 |
1971年 | 4篇 |
排序方式: 共有3523条查询结果,搜索用时 15 毫秒
1.
目的:探讨期刊审稿人的科研能力对创新效能感的影响,为期刊遴选优秀审稿人提供参考。方法:以《护理学报》为例,选取188名期刊审稿人为调查对象,采用科研能力自评量表及创新效能感量表,利用网络发放的方式进行调查。结果:期刊审稿人科研能力得分指标为79.47%,总分为(95.36±17.39)分;创新效能感得分指标为78.75%,总分为(31.50±5.11)分。期刊审稿人科研能力与创新效能感呈正相关(r =0.507,P<0.001)。问题发现能力、科研设计能力、科研实践能力对创新效能感均有预测作用(P<0.05)。结论:期刊审稿人的科研能力水平越高,其创新效能感越高。通过提升其问题发现能力、科研设计能力、科研实践能力可提高其创新效能感,提高审稿水平,确保审稿质量,更好地为读者与作者服务。 相似文献
2.
《Vaccine》2022,40(33):4748-4763
This work identifies the innovations that made it possible for the Bio-Manguinhos/Fiocruz Immunobiological Technology Institute to engage in the entire production of the Oxford/AstraZeneca vaccine (ChAdOx1 nCov-19) in Brazil, just 1.8 years after the COVID-19 pandemic was declared. The results were summarized in a case-based innovation model composed of 11 workstreams, 32 stages, 22 gates, 11 innovations, and 38 events. In terms of research contributions, three were found: (i) the identification of firm and government-level innovations allowing the substantial reduction in the COVID-19 vaccine time-to-market in Brazil; (ii) the presentation of empirical evidence supporting the new Outbreak Paradigm for vaccine research, development, and production; and (iii) the proposition of a conceptual model for describing innovations through the vaccine value chain in pandemic contexts, particularly when technology transfer is involved. 相似文献
3.
《Radiography》2022,28(3):739-745
IntroductionRecent advances in technology have seen the introduction of remote scanning capabilities become a reality for departments, allowing staff to remotely access, observe and even scan without being by the scanner side. The COVID-19 pandemic has accelerated use of remote working which also aligns with the direction of travel for healthcare more widely. However for technology to succeed it needs to be acceptable for use by radiographers in clinical practice.MethodsFollowing trial of a remote scanning technology, a group of radiographers were surveyed for their views on its use in practice. The survey was based on the Technology Acceptance Model as well as providing opportunity for open feedback on views regarding the technology.ResultsPerceived ease of use was high but appears to have little influence over overall intention to use. Perceived usefulness was lower and demonstrated correlations with attitude towards and intended use of the remote technology, suggesting that this is a key area to address which would positively impact on acceptance. Other considerations that would help support effective implementation were highlighted with the majority stating the technology as friend rather than foe.ConclusionAs an early evaluation of practitioner views on remote scanning within MRI, the results highlight the areas that would benefit from further development before further roll out in practice. A clear vision of its use and robust governance is needed to effectively support its implementation and acceptance by radiographers.Implications for practiceIntroducing remote scanning technology has potential to support training and share skills of experienced radiographers across multiple locations. It has the potential to transform the way MRI departments work and increase safer supervision to enable wider utilization of the support workforce. 相似文献
4.
《Research in social & administrative pharmacy》2022,18(4):2700-2705
Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed. 相似文献
5.
Cathy Eng Alexandre A. Jácome Prajnan Das George J. Chang Miguel Rodriguez-Bigas John M. Skibber Robert A. Wolff Wei Qiao Yan Xing Salil Sethi Aki Ohinata Christopher H. Crane 《Clinical colorectal cancer》2019,18(4):301-306
IntroductionSquamous cell carcinoma of the anal canal (SCCA) presents a rising incidence in the United States. Standard of care for locally advanced disease is comprised of infusional 5-fluorouracil with mitomycin C or cisplatin concurrent with radiation therapy (RT). We designed this trial to evaluate the efficacy and safety of a more convenient regimen composed of capecitabine and oxaliplatin.Patients and MethodsThis was a single-arm, phase II trial, with treatment-naive stage II to IIIB (TX,1-4NxM0) SCCA patients. The regimen was composed of capecitabine (825 mg/m2 twice per day for 5 days) and oxaliplatin (50 mg/m2 weekly) during weeks 1 through 6, concurrent with RT (XELOX-XRT; group 1). After the first 11 patients, the study was amended to omit chemotherapy during the third and sixth weeks (group 2). The primary objective was 3-year time to treatment failure (TTF) and safety. Secondary objectives were complete response (CR) rate, locoregional control, colostomy-free survival (CFS), and overall survival (OS).ResultsTwenty patients were enrolled. Seven patients of group 1 (63%) developed Grade 3 toxicity, which reduced to 22% in Group 2. No Grade 4 toxicities were noted. The median RT dose was 55 Gy. CR occurred in 100% of the 19 patients evaluable for response at 12 to 14 weeks. After a median follow-up of 47.6 months, 2 patients had local recurrence and 1 had distant recurrence. Three-year TTF was 90.0%, with similar rates between groups 1 and 2 (respectively, 90.9% vs. 88.8%, P = .984). Three-year CFS was 90.0%. The median OS has not been reached.ConclusionThe XELOX-XRT regimen is safe, with promising efficacy, and should be explored in larger trials for the treatment of locally advanced SCCA. 相似文献
6.
我国医学影像技术专业开设时间短,办学依托模式在各高校间存在较大差异,其中基于大学附属医院培养医学影像技术专业的模式存在课程体系逻辑不合理、教研机构设置不健全、学生创新研究引导不足等弊端,同时本文提出缓解上述不利教育因素的方案,旨在进一步完善高校附属医院主导医学影像技术专业建设的模式,输出更优质的人才。 相似文献
7.
8.
9.